evolocumab
amgen
['evolocumab', 'cardio']
who are the patients who develop new lesions despite therapy or pci? the multimodality imaging trial yellow-iii for evolocumab answers the question. watch my interview with dr. cal trial results dr. annapoorna subhash kini here #acc23 #wccardio #accesspoints 
Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | News Anchor https://t.co/7OIKCgMVAT | RT ≠ endorse | Disclaimer: https://t.co/bwmE2O3U5W